What Awaits Quest Diagnostics (DGX) in Q2 Earnings Release?
Yahoo Finance · 3 weeks ago
Open | 141.81 |
High | 144.71 |
Low | 141.90 |
Mkt Cap | 15.96B |
P/E (TTM) | 19.35 |
Div & Yield | 3.00 & 2.11% |
Prev. Close | 142.14 |
52 Wk. Low | 119.59 |
52 Wk. High | 150.59 |
Related stocks
Medical research company
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Wikipedia
(USD) | Q2 2024 | Y/Y |
---|---|---|
Revenue | 2.4B | 2.50% ▲ |
Net Income | 229M | 2.60% ▼ |
Diluted EPS | 2.35 | 1.00% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q3 2024 | $2.28 | - |
Q2 2024 | $2.34 | $2.35 |
Q1 2024 | $1.85 | $2.04 |
S&P 500^GSPC | 5,447.56-15.98 (-0.29%) |
Dow 30^DJI | 40,816.51+276.58 (+0.68%) |
Nasdaq^IXIC | 17,191.87-178.34 (-1.03%) |
104.24-6.59% | |
234.28-9.48% | |
423.93-0.65% |